中国胰腺癌诊治指南(2021)

2021-07-01 中华医学会外科学分会胰腺外科学组 中国实用外科杂志. 2021,41(07)

胰腺癌的发病率在世界范围内呈持续上升态势。2021年统计数据显示,在美国所有恶性肿瘤中,胰腺癌新发病例男性居第10位,女性居第9位,占恶性肿瘤相关病死率的第4位。中国国家癌症中心2017年统计数据显示

中文标题:

中国胰腺癌诊治指南(2021)

发布日期:

2021-07-01

简要介绍:

胰腺癌的发病率在世界范围内呈持续上升态势。2021年统计数据显示,在美国所有恶性肿瘤中,胰腺癌新发病例男性居第10位,女性居第9位,占恶性肿瘤相关病死率的第4位。中国国家癌症中心2017年统计数据显示,胰腺癌位列我国男性恶性肿瘤发病率的第7位,女性第11位,占恶性肿瘤相关病死率的第6位。作为预后极差的消化道肿瘤,胰腺癌具有早期诊断困难、手术切除率低、术后易复发转移等临床特点,临床诊治极具挑战性。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国胰腺癌诊治指南_2021_杨尹默.pdf)] GetToolGuiderByIdResponse(projectId=1, id=176601c002136624, title=中国胰腺癌诊治指南(2021), enTitle=, guiderFrom=中国实用外科杂志. 2021,41(07), authorId=0, author=, summary=胰腺癌的发病率在世界范围内呈持续上升态势。2021年统计数据显示,在美国所有恶性肿瘤中,胰腺癌新发病例男性居第10位,女性居第9位,占恶性肿瘤相关病死率的第4位。中国国家癌症中心2017年统计数据显示, cover=https://img.medsci.cn/2021725/1627226661091_2020535.jpg, journalId=0, articlesId=null, associationId=1158, associationName=中华医学会外科学分会胰腺外科学组, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jul 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">胰腺癌的发病率在世界范围内呈持续上升态势。2021年统计数据显示,在美国所有恶性肿瘤中,胰腺癌新发病例男性居第10位,女性居第9位,占恶性肿瘤相关病死率的第4位</span><span style="color: #666666;">。中国国家癌症中心2017年统计数据显示,胰腺癌位列我国男性恶性肿瘤发病率的第7位,女性第11位,占恶性肿瘤相关病死率的第6位</span><span style="color: #666666;">。作为预后极差的消化道肿瘤,胰腺癌具有早期诊断困难、手术切除率低、术后易复发转移等临床特点,临床诊治极具挑战性。&nbsp;</span></p>, tagList=[TagDto(tagId=718, tagName=胰腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=718, guiderKeyword=胰腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9498, appHits=720, showAppHits=0, pcHits=2233, showPcHits=8774, likes=10, shares=66, comments=41, approvalStatus=1, publishedTime=Sun Jul 25 23:40:28 CST 2021, publishedTimeString=2021-07-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 25 23:24:33 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:50:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国胰腺癌诊治指南_2021_杨尹默.pdf)])
中国胰腺癌诊治指南_2021_杨尹默.pdf
下载请点击:
评论区 (31)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1217126, encodeId=deaa121e12642, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Thu May 05 17:39:21 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204552, encodeId=ec55120455254, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9e51563073, createdName=pxddhbb, createdTime=Mon Mar 21 10:03:25 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203504, encodeId=eb5c1203504d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Thu Mar 17 16:50:59 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200006, encodeId=6cb712000060f, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef105479925, createdName=CHOWCHOW, createdTime=Sun Mar 06 20:39:40 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198314, encodeId=de311198314b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Tue Mar 01 11:40:34 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
    2022-05-05

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1217126, encodeId=deaa121e12642, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Thu May 05 17:39:21 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204552, encodeId=ec55120455254, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9e51563073, createdName=pxddhbb, createdTime=Mon Mar 21 10:03:25 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203504, encodeId=eb5c1203504d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Thu Mar 17 16:50:59 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200006, encodeId=6cb712000060f, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef105479925, createdName=CHOWCHOW, createdTime=Sun Mar 06 20:39:40 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198314, encodeId=de311198314b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Tue Mar 01 11:40:34 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
    2022-03-21 pxddhbb

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1217126, encodeId=deaa121e12642, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Thu May 05 17:39:21 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204552, encodeId=ec55120455254, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9e51563073, createdName=pxddhbb, createdTime=Mon Mar 21 10:03:25 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203504, encodeId=eb5c1203504d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Thu Mar 17 16:50:59 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200006, encodeId=6cb712000060f, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef105479925, createdName=CHOWCHOW, createdTime=Sun Mar 06 20:39:40 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198314, encodeId=de311198314b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Tue Mar 01 11:40:34 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
    2022-03-17 ms5000001712628444

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1217126, encodeId=deaa121e12642, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Thu May 05 17:39:21 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204552, encodeId=ec55120455254, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9e51563073, createdName=pxddhbb, createdTime=Mon Mar 21 10:03:25 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203504, encodeId=eb5c1203504d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Thu Mar 17 16:50:59 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200006, encodeId=6cb712000060f, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef105479925, createdName=CHOWCHOW, createdTime=Sun Mar 06 20:39:40 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198314, encodeId=de311198314b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Tue Mar 01 11:40:34 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
    2022-03-06 CHOWCHOW

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1217126, encodeId=deaa121e12642, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Thu May 05 17:39:21 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204552, encodeId=ec55120455254, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9e51563073, createdName=pxddhbb, createdTime=Mon Mar 21 10:03:25 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203504, encodeId=eb5c1203504d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c73c5484158, createdName=ms5000001712628444, createdTime=Thu Mar 17 16:50:59 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200006, encodeId=6cb712000060f, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef105479925, createdName=CHOWCHOW, createdTime=Sun Mar 06 20:39:40 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198314, encodeId=de311198314b0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e615597068, createdName=ms7000001910826648, createdTime=Tue Mar 01 11:40:34 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
    2022-03-01 ms7000001910826648

    学习

    0